Form 4: Nuvalent CEO Exercises Options and Sells Shares Under Pre-Arranged Plan

Nuvalent, Inc.'s President and CEO, James Richard Porter, exercised stock options and subsequently sold a portion of the acquired shares on July 15, 2025, under a pre-established Rule 10b5-1 trading plan.

Summary

• James Richard Porter, Nuvalent, Inc.'s President and CEO, exercised options to acquire 27,000 shares of Class A Common Stock at $18.93 per share on July 15, 2025.
• On the same day, Porter sold a total of 27,000 shares of Class A Common Stock in multiple transactions.
• The sales included 5,403 shares at a weighted average price of $81.64 (ranging from $80.97 to $81.96), 19,997 shares at $82.31 (ranging from $81.97 to $82.89), 1,496 shares at $83.94 (ranging from $83.29 to $84.20), and 104 shares at $84.53 (ranging from $84.51 to $84.54).
• Following these transactions, Porter directly beneficially owns 249,062 shares of Class A Common Stock and 303,400 stock options.
• All transactions were conducted under a Rule 10b5-1 trading plan adopted on April 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there are sales, they are part of a pre-arranged 10b5-1 plan, which mitigates the negative signal often associated with insider selling. The exercise of options also indicates the executive realizing value from their compensation.

Positives

• The exercise of stock options indicates the realization of value from previously granted equity incentives.
• Transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to managing equity rather than a reaction to immediate market conditions.

Negatives

• The sale of 27,000 shares by a key executive, even under a 10b5-1 plan, reduces their direct ownership stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could be perceived negatively, but the pre-arranged nature of the sale (10b5-1 plan) lessens concerns about a lack of confidence in the company's future. The exercise of options indicates the executive realizing value from their equity compensation.

Key Dates

Recommendation

Keywords

Nuvalent Inc., NUVL, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Executive Compensation, James Richard Porter, Biotechnology, Pharmaceuticals